BOI:EPA
Boiron USA
19,20 €
arrow_upward
+0,79%(+0,15) 1D
13 նոյ, 17:35:27 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
AOL.com
·
1 ժամ առաջ
‘65% of the S&P Is Basically AI’: Eisman’s Warning as Ramsey Tells Disabled Veteran His $500,000 Is ‘Safe’
CNBC
·
16 ժամ առաջ
Is a bottom in for the Nasdaq-100? Charts to watch
AP News
·
11 ժամ առաջ
Microsoft outage shows the risks of relying on a single technology provider for essential services
Investor's Business Daily
·
6 ժամ առաջ
How To Handle This Market; Nvidia Earnings, Anthropic IPO Ahead
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA